The effect of federal ban of RU 486 on medical research, new drug development, and pharmaceutical manufacturers
Subtitle: hearing before the Subcommittee on Regulation, Business Opportunities, and Energy of the Committee on Small Business, House of Representatives, One Hundred Second Congress, second session, Washington, DC, July 28, 1992.
Publisher: U.S. G.P.O.; For sale by the U.S. G.P.O., Supt. of Docs., Congressional Sales Office
Published: 1993
Place of publication: Washington
Language: eng
Number of pages: 144
Subjects: Mifepristone -- Government policy -- United States.; Pharmaceutical policy -- United States.; Medicine -- Research -- United States.; Import quotas -- United States.
Notes: Includes bibliographical references.
Distributed to some depository libraries in microfiche.
Shipping list no.: 93-0175-P.
"Serial no. 102-85."